{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:30:33Z","timestamp":1790746233969,"version":"4.1.0"},"reference-count":43,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AA021907"],"award-info":[{"award-number":["AA021907"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AA021902"],"award-info":[{"award-number":["AA021902"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Alcohol Clin Exp Res"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1111\/acer.13096","type":"journal-article","created":{"date-parts":[[2016,5,14]],"date-time":"2016-05-14T07:03:16Z","timestamp":1463209396000},"page":"1524-1530","source":"Crossref","is-referenced-by-count":29,"title":["Therapeutic Benefits of Spleen Tyrosine Kinase Inhibitor Administration on Binge Drinking-Induced Alcoholic Liver Injury, Steatosis, and Inflammation in Mice"],"prefix":"10.1111","volume":"40","author":[{"given":"Terence N.","family":"Bukong","sequence":"first","affiliation":[{"name":"University of Massachusetts Medical School; Worcester Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvin","family":"Iracheta-Vellve","sequence":"additional","affiliation":[{"name":"University of Massachusetts Medical School; Worcester Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedek","family":"Gyongyosi","sequence":"additional","affiliation":[{"name":"University of Massachusetts Medical School; Worcester Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Ambade","sequence":"additional","affiliation":[{"name":"University of Massachusetts Medical School; Worcester Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Catalano","sequence":"additional","affiliation":[{"name":"University of Massachusetts Medical School; Worcester Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Kodys","sequence":"additional","affiliation":[{"name":"University of Massachusetts Medical School; Worcester Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyongyi","family":"Szabo","sequence":"additional","affiliation":[{"name":"University of Massachusetts Medical School; Worcester Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,5,14]]},"reference":[{"key":"10.1111\/acer.13096-BIB0001|acer13096-cit-0001","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1182\/blood-2011-06-360743","article-title":"Critical role for Syk in responses to vascular injury","volume":"118","author":"Andre","year":"2011","journal-title":"Blood"},{"key":"10.1111\/acer.13096-BIB0002|acer13096-cit-0002","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1111\/j.1530-0277.2011.01577.x","article-title":"Elevated activation of ERK1 and ERK2 accompany enhanced liver injury following alcohol binge in chronically ethanol-fed rats","volume":"35","author":"Aroor","year":"2011","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/acer.13096-BIB0003|acer13096-cit-0003","first-page":"174","article-title":"Fostamatinib, a Syk inhibitor prodrug for the treatment of inflammatory diseases","volume":"12","author":"Bajpai","year":"2009","journal-title":"IDrugs"},{"key":"10.1111\/acer.13096-BIB0004|acer13096-cit-0004","doi-asserted-by":"crossref","first-page":"e96864","DOI":"10.1371\/journal.pone.0096864","article-title":"Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals","volume":"9","author":"Bala","year":"2014","journal-title":"PLoS One"},{"key":"10.1111\/acer.13096-BIB0005|acer13096-cit-0005","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1189\/jlb.0112050","article-title":"Induction of Bcl-3 by acute binge alcohol results in toll-like receptor 4\/LPS tolerance","volume":"92","author":"Bala","year":"2012","journal-title":"J Leukoc Biol"},{"key":"10.1111\/acer.13096-BIB0006|acer13096-cit-0006","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/bcp.12048","article-title":"Pharmacokinetics of fostamatinib, a spleen tyrosine kinase (SYK) inhibitor, in healthy human subjects following single and multiple oral dosing in three phase I studies","volume":"76","author":"Baluom","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/acer.13096-BIB0007|acer13096-cit-0007","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1515\/bc.2010.137","article-title":"Mechanisms and cell signaling in alcoholic liver disease","volume":"391","author":"Beier","year":"2010","journal-title":"Biol Chem"},{"key":"10.1111\/acer.13096-BIB0008|acer13096-cit-0008","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.alcohol.2012.08.004","article-title":"Rodent models of alcoholic liver disease: of mice and men","volume":"46","author":"Brandon-Warner","year":"2012","journal-title":"Alcohol"},{"key":"10.1111\/acer.13096-BIB0009|acer13096-cit-0009","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1124\/jpet.106.109058","article-title":"R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation","volume":"319","author":"Braselmann","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/acer.13096-BIB0010|acer13096-cit-0010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/labinvest.2015.152","article-title":"Versican: a novel modulator of hepatic fibrosis","volume":"96","author":"Bukong","year":"2016","journal-title":"Lab Invest"},{"key":"10.1111\/acer.13096-BIB0011|acer13096-cit-0011","first-page":"14","article-title":"Vital signs: binge drinking prevalence, frequency, and intensity among adults - United States, 2010","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1111\/acer.13096-BIB0012|acer13096-cit-0012","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/sj.icb7100030","article-title":"Tyrosine kinase Syk associates with toll-like receptor 4 and regulates signaling in human monocytic cells","volume":"85","author":"Chaudhary","year":"2007","journal-title":"Immunol Cell Biol"},{"key":"10.1111\/acer.13096-BIB0013|acer13096-cit-0013","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1037\/a0014414","article-title":"Binge drinking in young adults: data, definitions, and determinants","volume":"135","author":"Courtney","year":"2009","journal-title":"Psychol Bull"},{"key":"10.1111\/acer.13096-BIB0014|acer13096-cit-0014","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/eji.200737741","article-title":"Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors","volume":"38","author":"Dennehy","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1111\/acer.13096-BIB0015|acer13096-cit-0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2172-8-31","article-title":"Spleen tyrosine kinase Syk is critical for sustained leukocyte adhesion during inflammation in\u00a0vivo","volume":"8","author":"Frommhold","year":"2007","journal-title":"BMC Immunol"},{"key":"10.1111\/acer.13096-BIB0016|acer13096-cit-0016","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12967-015-0552-7","article-title":"Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice","volume":"13","author":"Ganz","year":"2015","journal-title":"J Transl Med"},{"key":"10.1111\/acer.13096-BIB0017|acer13096-cit-0017","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/art.30114","article-title":"An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents","volume":"63","author":"Genovese","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1111\/acer.13096-BIB0018|acer13096-cit-0018","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1360-0443.2008.02493.x","article-title":"Drinking patterns, dependency and life-time drinking history in alcohol-related liver disease","volume":"104","author":"Hatton","year":"2009","journal-title":"Addiction"},{"key":"10.1111\/acer.13096-BIB0019|acer13096-cit-0019","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1158\/0008-5472.CAN-13-2104","article-title":"Expression of variant isoforms of the tyrosine kinase SYK determines the prognosis of hepatocellular carcinoma","volume":"74","author":"Hong","year":"2014","journal-title":"Cancer Res"},{"key":"10.1111\/acer.13096-BIB0020|acer13096-cit-0020","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2177\/jsci.35.56","article-title":"Involvement of Syk in pathology of systemic autoimmune disease","volume":"35","author":"Iwata","year":"2012","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"10.1111\/acer.13096-BIB0021|acer13096-cit-0021","doi-asserted-by":"crossref","first-page":"G1416","DOI":"10.1152\/ajpgi.00026.2012","article-title":"Inhibition of Syk activity by R788 in platelets prevents remote lung tissue damage after mesenteric ischemia-reperfusion injury","volume":"302","author":"Lapchak","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1111\/acer.13096-BIB0022|acer13096-cit-0022","first-page":"1988","article-title":"Syk-mediated tyrosine phosphorylation of mule promotes TNF-induced JNK activation and cell death","volume":"25","author":"Lee","year":"2015","journal-title":"Oncogene"},{"key":"10.1111\/acer.13096-BIB0023|acer13096-cit-0023","doi-asserted-by":"crossref","first-page":"R146","DOI":"10.1186\/ar4329","article-title":"Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy","volume":"15","author":"Liao","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1111\/acer.13096-BIB0024|acer13096-cit-0024","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.molimm.2010.01.008","article-title":"Anti-inflammatory actions of Syk inhibitors in macrophages involve non-specific inhibition of toll-like receptors-mediated JNK signaling pathway","volume":"47","author":"Lin","year":"2010","journal-title":"Mol Immunol"},{"key":"10.1111\/acer.13096-BIB0025|acer13096-cit-0025","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrgastro.2015.35","article-title":"Alcoholic liver disease: mechanisms of injury and targeted treatment","volume":"12","author":"Louvet","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1111\/acer.13096-BIB0026|acer13096-cit-0026","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/ki.2015.29","article-title":"Correlation of disease activity in proliferative glomerulonephritis with glomerular spleen tyrosine kinase expression","volume":"88","author":"McAdoo","year":"2015","journal-title":"Kidney Int"},{"key":"10.1111\/acer.13096-BIB0027|acer13096-cit-0027","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1476-5381.2012.02097.x","article-title":"The SYK side of TLR4: signalling mechanisms in response to LPS and minimally oxidized LDL","volume":"167","author":"Miller","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1111\/acer.13096-BIB0028|acer13096-cit-0028","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nri2765","article-title":"The SYK tyrosine kinase: a crucial player in diverse biological functions","volume":"10","author":"Mocsai","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/acer.13096-BIB0029|acer13096-cit-0029","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/187221312800166895","article-title":"The 2010 patent landscape for spleen tyrosine kinase inhibitors","volume":"6","author":"Moretto","year":"2012","journal-title":"Recent Pat Inflammation Allergy Drug Discovery"},{"key":"10.1111\/acer.13096-BIB0030|acer13096-cit-0030","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1172\/JCI60777","article-title":"IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice","volume":"122","author":"Petrasek","year":"2012","journal-title":"J Clin Investig"},{"key":"10.1111\/acer.13096-BIB0031|acer13096-cit-0031","doi-asserted-by":"crossref","first-page":"16544","DOI":"10.1073\/pnas.1308331110","article-title":"STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease","volume":"110","author":"Petrasek","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/acer.13096-BIB0032|acer13096-cit-0032","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ccr.2014.01.022","article-title":"SYK is a critical regulator of FLT3 in acute myeloid leukemia","volume":"25","author":"Puissant","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1111\/acer.13096-BIB0033|acer13096-cit-0033","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/187152809788462626","article-title":"Syk: a novel target for treatment of inflammation in lung disease","volume":"8","author":"Sanderson","year":"2009","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1111\/acer.13096-BIB0034|acer13096-cit-0034","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2165\/11591480-000000000-00000","article-title":"Role of spleen tyrosine kinase inhibitors in the management of rheumatoid arthritis","volume":"71","author":"Scott","year":"2011","journal-title":"Drugs"},{"key":"10.1111\/acer.13096-BIB0035|acer13096-cit-0035","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1172\/JCI44271","article-title":"Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice","volume":"121","author":"Seale","year":"2011","journal-title":"J Clin Investig"},{"key":"10.1111\/acer.13096-BIB0036|acer13096-cit-0036","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cmet.2007.06.001","article-title":"Transcriptional control of brown fat determination by PRDM16","volume":"6","author":"Seale","year":"2007","journal-title":"Cell Metab"},{"key":"10.1111\/acer.13096-BIB0037|acer13096-cit-0037","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/acer.12011","article-title":"Binge ethanol and liver: new molecular developments","volume":"37","author":"Shukla","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/acer.13096-BIB0038|acer13096-cit-0038","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/j.gastro.2014.10.042","article-title":"Gut-liver axis in alcoholic liver disease","volume":"148","author":"Szabo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1111\/acer.13096-BIB0039|acer13096-cit-0039","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3748\/wjg.v16.i11.1321","article-title":"Alcoholic liver disease and the gut-liver axis","volume":"16","author":"Szabo","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1111\/acer.13096-BIB0040|acer13096-cit-0040","first-page":"87","article-title":"Focus on: alcohol and the liver","volume":"33","author":"Szabo","year":"2010","journal-title":"Alcohol Res Health"},{"key":"10.1111\/acer.13096-BIB0041|acer13096-cit-0041","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4155\/ppa.14.34","article-title":"New spleen tyrosine kinase inhibitors: patent applications published during 2011-2013","volume":"3","author":"Thorarensen","year":"2014","journal-title":"Pharm Pat Anal"},{"key":"10.1111\/acer.13096-BIB0042|acer13096-cit-0042","first-page":"285","article-title":"Dangerous byproducts of alcohol breakdown-focus on adducts","volume":"27","author":"Tuma","year":"2003","journal-title":"Alcohol Res Health"},{"key":"10.1111\/acer.13096-BIB0043|acer13096-cit-0043","doi-asserted-by":"crossref","first-page":"270302","DOI":"10.1155\/2014\/270302","article-title":"Functional roles of Syk in macrophage-mediated inflammatory responses","volume":"2014","author":"Yi","year":"2014","journal-title":"Mediators Inflamm"}],"container-title":["Alcoholism: Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Facer.13096","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/acer.13096\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T16:45:15Z","timestamp":1625503515000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/acer.13096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,14]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"URL":"https:\/\/doi.org\/10.1111\/acer.13096","archive":["Portico"],"relation":{},"ISSN":["0145-6008"],"issn-type":[{"value":"0145-6008","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5,14]]}}}